BackJanux Therapeutics Overview

Janux Therapeutics Total Liabilities

Janux Therapeutics's total liabilities is $87M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$86.69M
126.33% YoYΔ $48.39M vs prior year quarter

Peer average

Loading

Janux Therapeutics Total Liabilities History

Loading

Janux Therapeutics vs. peers: Total Liabilities Comparison

Loading

Janux Therapeutics Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Janux Therapeutics (JANX) FAQ

As of the most recent data (March 2026), JANX shows a total liabilities of $87M. That compares with $38M in the prior-year period — up 126.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, JANX's total liabilities is now $87M (was $38M) — a 126.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Janux Therapeutics is outperforming or lagging.

Tracking JANX's total liabilities over time shows whether Janux Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $87M That compares with $38M in the prior-year period — up 126.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Janux Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $87M) with ownership activity and broader fundamentals.

Janux Therapeutics's total liabilities is $87M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.